Rapid change in prescribing behavior in hospitals participating in get with the guidelines-stroke after release of the management of atherothrombosis with clopidogrel in high-risk patients (MATCH) clinical trial results

Stroke

Volumn 41, Issue 9, 2010, Pages 2094-2097

  Menon, Bijoy K ^a   Frankel, Michael R ^b   Liang, Li ^c   Labresh, Kenneth A ^d   Ellrodt, Gray ^e   Hernandez, Adrian F ^c   Fonarow, Gregg C ^f   Schwamm, Lee H ^g   Smith, Eric E ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d RTI INTERNATIONAL   (United States)

^e BERKSHIRE MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

antiplatelet drugs; antithrombotics; health services research; ischemic stroke; quality of care

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; WARFARIN; TICLOPIDINE;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; BRAIN ISCHEMIA; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DRUG COMBINATION; TRENDS; UNITED STATES;

ASPIRIN; BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PRESCRIPTIONS; STROKE; TICLOPIDINE; UNITED STATES;

EID: 77956398225     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.584151     Document Type: Article

References (9)

1. Majumdar SR, Inui TS, Gurwitz JH, Gillman MW, McLaughlin TJ, Soumerai SB. Influence of physician specialty on adoption and relin-quishment of calcium channel blockers and other treatments for myo-cardial infarction. J Gen Intern Med. 2001;16:351-359.
2. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-337.
3. Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith EE, Ellrodt G, Cannon CP, Liang L, Peterson E, Labresh KA. Get With The Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation. 2009;119:107-115.
4. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke. Circulation. 2006;113:e409-449.
5. Steinhubl SR, Berger PB, Mann JT III, Fry ET, DeLago A, Wilmer C, Topol EJ. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411-2420.
6. Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ische-mic Events (CURE) trial. Circulation. 2004;110:1202-1208.
7. Vogel TR, Dombrovskiy VY, Graham AM. Carotid artery stenting in the nation: the influence of hospital and physician volume on outcomes. Vasc Endovascular Surg. 2010;44:89-94.
8. Stafford RS, Furberg CD, Finkelstein SN, Cockburn IM, Alehegn T, Ma J. Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002. JAMA. 2004;291:54-62.
9. Hills NK, Johnston SC. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack. Stroke. 2008;39:1228-1232.